Paper40596256
Deciphering the interaction between N-palmitoyl-D-glucosamine and the endocannabinoidome.
Schiano Moriello A and 7 others. Sci Rep, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Deciphering the interaction between N-palmitoyl-D-glucosamine and the endocannabinoidome. Papers, record 40596256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40596256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deciphering the interaction between N-palmitoyl-D-glucosamine and the endocannabinoidome.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endocannabinoids | Major topic |
| Palmitic Acids | Major topic |
| Humans | |
| Arachidonic Acids | |
| Polyunsaturated Alkamides | |
| Glycerides | |
| Cell Line | |
| Ethanolamines | |
| Amides |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| F/200052/01/X45 | Ministero dello Sviluppo Economico | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38249555 | Uroprotective and pain-relieving effect of dietary supplementation with micronized palmitoyl-glucosamine and hesperidin in a chronic model of cyclophosphamide-induced cystitis. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/38249555 | PubMed |
| 2 | 8931279 | Nerve growth factor: from neurotrophin to neurokine. | Trends Neurosci | 1996 | https://conductscience.org/library/papers/8931279 | PubMed |
| 3 | 9468498 | Dictyostelium discoideum fatty-acyl amidase II has deacylase activity on Rhizobium nodulation factors. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9468498 | PubMed |
| 4 | 36747264 | Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain. | BMC Vet Res | 2023 | https://conductscience.org/library/papers/36747264 | PubMed |
| 5 | 11145231 | Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting. | Pharm Res | 2000 | https://conductscience.org/library/papers/11145231 | PubMed |
| 6 | 17876302 | The orphan receptor GPR55 is a novel cannabinoid receptor. | Br J Pharmacol | 2007 | https://conductscience.org/library/papers/17876302 | PubMed |
| 7 | 31878942 | Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity. | J Neuroinflammation | 2019 | https://conductscience.org/library/papers/31878942 | PubMed |
| 8 | 31779692 | Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain. | Arthritis Res Ther | 2019 | https://conductscience.org/library/papers/31779692 | PubMed |
| 9 | 7505999 | A proposed autacoid mechanism controlling mastocyte behaviour. | Agents Actions | 1993 | https://conductscience.org/library/papers/7505999 | PubMed |
| 10 | 28336953 | Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor. | Sci Rep | 2017 | https://conductscience.org/library/papers/28336953 | PubMed |
| 11 | 10440374 | Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. | Nature | 1999 | https://conductscience.org/library/papers/10440374 | PubMed |
| 12 | 29615912 | Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29615912 | PubMed |
| 13 | 27539936 | The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. | Br J Pharmacol | 2017 | https://conductscience.org/library/papers/27539936 | PubMed |
| 14 | 26965148 | Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. | Prog Lipid Res | 2016 | https://conductscience.org/library/papers/26965148 | PubMed |
| 15 | 33333772 | Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33333772 | PubMed |
| 16 | 25598150 | The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. | Br J Pharmacol | 2016 | https://conductscience.org/library/papers/25598150 | PubMed |
| 17 | 39235753 | N-palmitoyl-d-glucosamine limits mucosal damage and VEGF-mediated angiogenesis by PPARα-dependent suppression of pAkt/mTOR/HIF1α pathway and increase in PEA levels in AOM/DSS colorectal carcinoma in mice. | Phytother Res | 2024 | https://conductscience.org/library/papers/39235753 | PubMed |
| 18 | 10359581 | MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. | J Exp Med | 1999 | https://conductscience.org/library/papers/10359581 | PubMed |
| 19 | 18695637 | 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18695637 | PubMed |
| 20 | 15465922 | The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. | Mol Pharmacol | 2005 | https://conductscience.org/library/papers/15465922 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41226728 | Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226728 |
Source PubMed
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABHD4 | 63874 | PubTator's text mining | https://conductscience.org/library/genes/63874 | NCBI Gene |
| DAGLB | 221955 | PubTator's text mining | https://conductscience.org/library/genes/221955 | NCBI Gene |
| FAAH | 2166 | PubTator's text mining | https://conductscience.org/library/genes/2166 | NCBI Gene |
| GDE1 | 51573 | PubTator's text mining | https://conductscience.org/library/genes/51573 | NCBI Gene |
| MGLL | 11343 | PubTator's text mining | https://conductscience.org/library/genes/11343 | NCBI Gene |
| NAPEPLD | 222236 | PubTator's text mining | https://conductscience.org/library/genes/222236 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40596256
GET https://conductscience.org/api/papers/v1/40596256/references?page=2